ENTITY WIDE DISCLOSURES - Summary of Revenue by Major Source (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Disaggregation Of Revenue [Line Items]
Total revenue	$ 1,885,842	$ 1,459,996	$ 1,142,377
Oncology
Disaggregation Of Revenue [Line Items]
Total revenue	587,097	467,796	362,846
Other
Disaggregation Of Revenue [Line Items]
Total revenue	404,844	296,914	267,415
Metabolic
Disaggregation Of Revenue [Line Items]
Total revenue	376,842	244,682	159,900
Cardiology
Disaggregation Of Revenue [Line Items]
Total revenue	193,690	174,634	119,692
AVAI
Disaggregation Of Revenue [Line Items]
Total revenue	163,312	118,031	110,976
Central Nervous System
Disaggregation Of Revenue [Line Items]
Total revenue	160,057	157,939	121,548
Revenue net
Disaggregation Of Revenue [Line Items]
Total revenue	$ 1,885,842	$ 1,459,996	$ 1,142,377